Grants and Contributions

This award was established to recognize the excellence of cancer research being conducted in Canada. This award will be given annually to the highest-ranking Early Career Researchers in the Project Grant competition that fall within the CIHR Institute of Cancer Research (CIHR-ICR) mandate:
• ICR has a mandate to support research that reduces the burden of cancer on individuals and families through prevention strategies, screening, diagnosis, effective treatments, psycho-social support systems, and palliation.

The CIHR Institute of Gender and Health (CIHR-IGH) will fund applications that are relevant to its mandate and research priorities, as described in our new Research Priority Plan, and that are aligned with at least one of the following research areas.

This Priority Announcement (PA) is led by the Institute of Circulatory and Respiratory Health (CIHR-ICRH) in partnership with Cystic Fibrosis Canada.

The CIHR-ICRH has the broad mandate of supporting research on the heart, lung, brain (stroke), blood, blood vessels, critical and intensive care, and sleep.

The CIHR Institute of Cancer Research (CIHR-ICR) has a mandate to support research that reduces the burden of cancer on individuals and families through prevention strategies, screening, diagnosis, effective treatments, psycho-social support systems, and palliation.

This PA will fund Cancer research in the following priority areas:

• Cancer Prevention and/or Early Detection of Cancer
o research that prevents the onset of cancer (lowers cancer risk) and/or reduces the severity of the disease through early detection when it is at its most treatable

The CIHR Institute of Indigenous Peoples’ Health (CIHR-IIPH) will provide funding for applications that are relevant to its mandate

CRPPHE will offer funding for bridge grants to research projects that are aligned with the CRPPHE goal and objectives and the CRPPHE Interim Investment Plan 2023-2025, and that have a primary research objective related to preparing for and/or responding to existing and future pandemics and other health emergencies*.

*For the purpose of this Priority Announcement, a health emergency is defined as:

A present or imminent event or phenomenon, of a temporary, acute nature, with actual or potential significant negative impacts on human health, resulting in:
• A serious disruption of the functioning of a community; and/or
• The declaration of a state of emergency by a municipal, provincial/territorial, federal and/or Indigenous government, or international organization with a health research mandate, and that;
• Requires prompt research action to protect and strengthen human health.

This Priority Announcement (PA) is led by Canada’s Strategy for Patient-Oriented Research and aims to support Patient-Oriented Research (POR*) projects and Innovative Clinical Trials (iCT) projects.

This Priority Announcement (PA) is led by Canada’s Strategy for Patient-Oriented Research and aims to support Patient-Oriented Research (POR*) projects and Innovative Clinical Trials (iCT) projects.

The CIHR Institute of Cancer Research (CIHR-ICR) has a mandate to support research that reduces the burden of cancer on individuals and families through prevention strategies, screening, diagnosis, effective treatments, psycho-social support systems, and palliation.
This PA will fund Breast Cancer research in the following priority areas:
• General Breast Cancer Research
o research that supports CIHR-ICR’s mandate in the area of Breast Cancer.
• Breast Cancer Prevention and/or Early Detection of Breast Cancer
o research that prevents the onset of breast cancer (lowers cancer risk) and/or reduces the severity of the disease through early detection when it is at its most treatable.
• Breast Cancer Survivorship
o research that mitigates the challenges experienced along the breast cancer survivorship journey and improves the health outcomes for breast cancer survivors of all ages after cancer treatment ends.
o specifically in the areas of:
¿ Late and long-term effects of cancer treatment
¿ Survivors’ experiences and outcomes
¿ Models of care for cancer survivorship
o This PA will not fund research focused on improving end-of-life care.
• This PA supports research that creates new knowledge and/or moves it into practice in the health system, communities, workplaces, and in the daily lives of Canadians.

The CIHR Institute of Cancer Research (CIHR-ICR) has a mandate to support research that reduces the burden of cancer on individuals and families through prevention strategies, screening, diagnosis, effective treatments, psycho-social support systems, and palliation.
This PA will fund Breast Cancer research in the following priority areas:
• General Breast Cancer Research
o research that supports CIHR-ICR’s mandate in the area of Breast Cancer.
• Breast Cancer Prevention and/or Early Detection of Breast Cancer
o research that prevents the onset of breast cancer (lowers cancer risk) and/or reduces the severity of the disease through early detection when it is at its most treatable.
• Breast Cancer Survivorship
o research that mitigates the challenges experienced along the breast cancer survivorship journey and improves the health outcomes for breast cancer survivors of all ages after cancer treatment ends.
o specifically in the areas of:
¿ Late and long-term effects of cancer treatment
¿ Survivors’ experiences and outcomes
¿ Models of care for cancer survivorship
o This PA will not fund research focused on improving end-of-life care.
• This PA supports research that creates new knowledge and/or moves it into practice in the health system, communities, workplaces, and in the daily lives of Canadians.